Malek NP - Search Results

1

Hypoxia induced Sonic Hedgehog signaling regulates cancer stemness, epithelial-to-mesenchymal transition and invasion in cholangiocarcinoma.

Bhuria V, Xing J, Scholta T, Bui KC, Nguyen MLT, Malek NP, Bozko P, Plentz RR. Bhuria V, et al. Among authors: malek np. Exp Cell Res. 2019 Dec 15;385(2):111671. doi: 10.1016/j.yexcr.2019.111671. Epub 2019 Oct 18. Exp Cell Res. 2019. PMID: 31634481

2

Activation of Notch signaling is required for cholangiocarcinoma progression and is enhanced by inactivation of p53 in vivo.

El Khatib M, Bozko P, Palagani V, Malek NP, Wilkens L, Plentz RR. El Khatib M, et al. Among authors: malek np. PLoS One. 2013 Oct 30;8(10):e77433. doi: 10.1371/journal.pone.0077433. eCollection 2013. PLoS One. 2013. PMID: 24204826 Free PMC article.

3

Comparative study of antitumor effects of bromelain and papain in human cholangiocarcinoma cell lines.

Müller A, Barat S, Chen X, Bui KC, Bozko P, Malek NP, Plentz RR. Müller A, et al. Among authors: malek np. Int J Oncol. 2016 May;48(5):2025-34. doi: 10.3892/ijo.2016.3411. Epub 2016 Mar 1. Int J Oncol. 2016. PMID: 26935541

4

Silencing of Kangai 1 C-terminal interacting tetraspanin suppresses progression of cholangiocarcinoma.

Bui KC, Barat S, Chen X, Bozko P, Scholta T, Nguyen MLT, Bhuria V, Xing J, Nguyen LT, Le HS, Velavan TP, Sipos B, Wilkens L, Malek NP, Plentz RR. Bui KC, et al. Among authors: malek np. Exp Cell Res. 2018 Mar 1;364(1):59-67. doi: 10.1016/j.yexcr.2018.01.028. Epub 2018 Jan 31. Exp Cell Res. 2018. PMID: 29366806

5

Epithelial mesenchymal transition and pancreatic tumor initiating CD44+/EpCAM+ cells are inhibited by γ-secretase inhibitor IX.

Palagani V, El Khatib M, Kossatz U, Bozko P, Müller MR, Manns MP, Krech T, Malek NP, Plentz RR. Palagani V, et al. Among authors: malek np. PLoS One. 2012;7(10):e46514. doi: 10.1371/journal.pone.0046514. Epub 2012 Oct 19. PLoS One. 2012. PMID: 23094026 Free PMC article.

6

Inhibition of hedgehog signaling attenuates carcinogenesis in vitro and increases necrosis of cholangiocellular carcinoma.

El Khatib M, Kalnytska A, Palagani V, Kossatz U, Manns MP, Malek NP, Wilkens L, Plentz RR. El Khatib M, et al. Among authors: malek np. Hepatology. 2013 Mar;57(3):1035-45. doi: 10.1002/hep.26147. Epub 2013 Jan 25. Hepatology. 2013. PMID: 23172661

7

Combined inhibition of Notch and JAK/STAT is superior to monotherapies and impairs pancreatic cancer progression.

Palagani V, Bozko P, El Khatib M, Belahmer H, Giese N, Sipos B, Malek NP, Plentz RR. Palagani V, et al. Among authors: malek np. Carcinogenesis. 2014 Apr;35(4):859-66. doi: 10.1093/carcin/bgt394. Epub 2013 Nov 30. Carcinogenesis. 2014. PMID: 24293409

8

Capsaicin treatment attenuates cholangiocarcinoma carcinogenesis.

Wutka A, Palagani V, Barat S, Chen X, El Khatib M, Götze J, Belahmer H, Zender S, Bozko P, Malek NP, Plentz RR. Wutka A, et al. Among authors: malek np. PLoS One. 2014 Apr 18;9(4):e95605. doi: 10.1371/journal.pone.0095605. eCollection 2014. PLoS One. 2014. PMID: 24748170 Free PMC article.

9

Clinical presentation, risk factors and staging systems of cholangiocarcinoma.

Plentz RR, Malek NP. Plentz RR, et al. Among authors: malek np. Best Pract Res Clin Gastroenterol. 2015 Apr;29(2):245-52. doi: 10.1016/j.bpg.2015.02.001. Epub 2015 Feb 14. Best Pract Res Clin Gastroenterol. 2015. PMID: 25966425 Review.

10

Targeting c-MET by LY2801653 for treatment of cholangiocarcinoma.

Barat S, Bozko P, Chen X, Scholta T, Hanert F, Götze J, Malek NP, Wilkens L, Plentz RR. Barat S, et al. Among authors: malek np. Mol Carcinog. 2016 Dec;55(12):2037-2050. doi: 10.1002/mc.22449. Epub 2016 Jan 12. Mol Carcinog. 2016. PMID: 26757360

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

223 results

Search Page